| Previous Close | 0.4000 |
| Open | 0.4100 |
| Bid | 0.0000 x |
| Ask | 0.0000 x |
| Day's Range | 0.4001 - 0.4300 |
| 52 Week Range | 0.3600 - 3.2600 |
| Volume | 299,360 |
| Avg. Volume | 428,534 |
| Market Cap | 24.46M |
| Beta | 2.35 |
| PE Ratio (TTM) | -0.57 |
| EPS (TTM) | -0.72 |
| Earnings Date | May 4, 2017 - May 8, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.00 |
- Zacks•8 days ago
Implied Volatility Surging For CorMedix Inc (CRMD) Stock Options
CorMedix Inc (CRMD) Stock looks to be lucrative to the option traders on the back of its surging implied volatility.
- Accesswire•10 days ago
CorMedix Inc. Provides Comprehensive Pipeline Update During Research and Development Day
Live Webcast Today, July 12, 2017, beginning at 8:30am ET BEDMINSTER, NJ / ACCESSWIRE / July 12, 2017 / CorMedix Inc. (NYSE MKT: CRMD), a biopharmaceutical company focused on developing and commercializing ...
- Accesswire•26 days ago
CorMedix Inc. Appoints Mehmood Khan, M.D. and Steven Lefkowitz to its Board of Directors
Gary Gelbfish, M.D. Appointed as Observer to the Company's Board of Directors by Elliott Management BEDMINSTER, NJ / ACCESSWIRE / June 26, 2017 / CorMedix Inc. (NYSE MKT: CRMD), a biopharmaceutical company ...
